Atezolizumab and bevacizumab for hepatocellular carcinoma: How to approach salvage therapy for non-responders?: Editorial on "Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study"

阿特珠单抗和贝伐珠单抗治疗肝细胞癌：如何对无反应者进行挽救治疗？：关于“阿特珠单抗/贝伐珠单抗治疗失败后，索拉非尼与乐伐替尼治疗晚期肝细胞癌：一项真实世界研究”的社论